Key Highlights

● Cellebrite DI climbed on Friday, closing at $11.53.

● Cellebrite edged past third-quarter profit expectations.

● Its chief executive pointed to better execution.

● Nvidia reports quarterly results on Tuesday, November 17.

Cellebrite DI (NASDAQ:CLBT) was among the gainers trending on the Nasdaq Composite on Friday, November 13, 2026, with its shares climbing to close at $11.53. The advance came a day after the company reported third-quarter 2026 results on November 12.

Cellebrite posted adjusted Earnings of 17 cents a share, a penny ahead of the 16-cent consensus estimate, according to market data. Chief Executive Shiv Ramji highlighted improved performance in the quarter, saying in a statement: "Cellebrite executed better in the third quarter." His statement went on to single out annual recurring revenue, revenue and adjusted EBITDA as finishing above a benchmark that was not specified in the excerpt available.

An analyst trims, but stays positive

Not every reaction was a straight upgrade. JPMorgan (NYSE:JPM) cut its price target on Cellebrite to $15 from $16 while keeping an Overweight rating, according to market data. A small target reduction alongside a positive rating often reflects adjustments to valuation assumptions rather than a change in an analyst's overall view, and JPMorgan's new target still sits above where the stock closed on Friday.

What Cellebrite does

Cellebrite provides digital intelligence and forensics tools used by law enforcement agencies, governments and enterprises to collect and analyze data from phones, computers and other devices during investigations. Annual recurring revenue, or ARR, is one of the metrics the company highlights, and investors in software businesses tend to watch it closely. Recurring Revenue tends to be more predictable than one-time sales, and growth in ARR can signal that customers are renewing and expanding their use of the company's products.

When a company in this position beats profit expectations and points to strength in its key metrics, investors often read it as a sign of improving execution, which can support the stock even if the beat itself is modest.

A market favoring company-specific stories

Cellebrite's gain came against a difficult backdrop for much of the tech sector. The Nasdaq Composite closed at 25,136.27, down 229.82 points, as semiconductors and AI-hardware stocks slid after Nvidia (NASDAQ:NVDA)'s Leadership change. Jensen Huang resigned as Nvidia's chief executive on November 12, and CFO Colette Kress was named interim CEO.

The S&P 500 fell 30.73 points to 7,561.67, while the Dow Jones Industrial Average edged up 50.46 points to 52,347.55, the only major average to gain. The Russell 2000 dipped 8.57 points to 2,790.49. Money rotated away from chips and toward consumer staples, energy, payments and banks, and stocks with their own positive news flow tended to hold up better than those tied to the AI hardware trade.

Rate worries remained in the background. October producer prices cooled month on month but posted their hottest annual pace since November 2022, and the 10-year Treasury Yield climbed to its highest since October. Traders see a rate hike at the Federal Reserve's December 8–9 meeting as near-certain, and Chicago Fed President Austan Goolsbee said, "Inflation is rising. It's proved far more persistent than we predicted."

What to watch next for Cellebrite DI

For Cellebrite, the focus will be on whether the company can sustain the improved execution it described, particularly in ARR growth and profitability. Investors will be watching future quarters for signs that the Business is building momentum in its subscription offerings.

More broadly, Nvidia reports results on Tuesday, November 17, and the Federal Reserve releases its meeting minutes on Wednesday. Both events could shape sentiment across technology stocks, including software names like Cellebrite, as traders weigh a hawkish Fed against corporate results.